A bio-assay for effectors of osteoclast differentiation in serum from patients with bone disease

Clinica Chimica Acta

Volumn 356, Issue 1-2, 2005, Pages 154-163

  Dugard, Marit Naomi ^a   Sharp, C A ^a   Evans, S F ^a   Williams, J H H ^a,b   Davie, M W J ^a   Marshall, M J ^a  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHESTER   (United Kingdom)

Author keywords

Bio assay; Bone disease; Differentiation; Osteoclast; RANKL; Serum

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; MARKER; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BIOASSAY; BONE DENSITY; BONE DISEASE; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALE; MEASUREMENT; MODEL; OSTEOCLAST; OSTEOLYSIS; PATIENT; PRIORITY JOURNAL; SERUM;

ACID PHOSPHATASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL ASSAY; BONE DENSITY; BONE DISEASES; CARRIER PROTEINS; CELL DIFFERENTIATION; FEMALE; HUMANS; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; OSTEITIS DEFORMANS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 20344404700     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.01.020     Document Type: Article

References (32)

1. D.L. Lacey, E. Timms, T.L. Tan, M.J. Kelley, C.R. Dunstan, and T. Burgess Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
2. T. Suda, N. Udagawa, I. Nakamura, C. Miyaura, and N. Takahashi Modulation of osteoclast differentiation by local factors Bone 17 2:Suppl. 1995 91S
3. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumour necrosis factor receptor and ligand families Endocr Rev 20 1999 345 357
4. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, and S. Mochizuki Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci 95 1998 3597 3602
5. K. Fuller, B. Wong, S. Fox, Y. Choi, and T.J. Chambers TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption by osteoclasts J Exp Med 188 1998 997 1001
6. N. Udagawa, N. Takahashi, E. Jimi, K. Matsuzaki, T. Tsurukai, and K. Itoh Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor Bone 25 1999 517 523
7. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.-S. Chang, and R. Lüthy Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
8. L.C. Hofbauer, C.R. Dunstan, T.C. Spelsberg, B.L. Riggs, and S. Khosla Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines Biochem Biophys Res Commun 250 1998 776 781
9. J.E. Aubin, and E. Bonnelye Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption Osteoporos Int 11 2000 905 913
10. K. Thirunavukkarasu, R.R. Miles, D.L. Halladay, X. Yang, R.J. Galvin, and S. Chandrasekhar Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects J Biol Chem 276 2001 36241 36250
11. L. Alvarez, P. Peris, N. Gunnabens, S. Vidal, I. Ros, and F. Pons Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates Arthritis Rheum 48 2003 824 828
12. L.C. Hofbauer, M. Schoppet, P. Schuller, V. Viereck, and M. Christ Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women Clin Endocrinol 60 2004 214 219
13. A.J. Janckila, K. Takahashi, S.Z. Sun, and L.T. Yam Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b J Bone Miner Res 16 2001 788 793
14. D.O. Slosman, R. Rizzoli, A. Donath, and J.-Ph. Bonjour Vertebral bone mineral density measured laterally by dual-energy X-ray absorptiometry Osteoporos Int 1 1990 23 29
15. G.N. Andersson, and S.C. Marks Jr. Tartrate-resistant acid ATPase as a cytochemical marker for osteoclasts J Histochem Cytochem 37 1989 115 117
16. P.T. Lakkakorpi, and H.K. Väänänen Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro J Bone Miner Res 6 1991 817 826
17. L.T. Duong, P. Lakkakorpi, I. Nakamura, and G.A. Rodan Integrins and signalling in osteoclast function Matrix Biol 19 2000 97 105
18. J. Lam, S. Takeshita, J.E. Barker, O. Kanagawa, F.P. Ross, and S.L. Teitelbaum TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand J Clin Invest 106 2000 1481 1488
19. L. Xing, L. Carlson, B. Story, Z. Tai, P. Keng, and U. Siebenlist Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption J Bone Miner Res 18 2003 260 269
20. W. Huang, M.H. Drissi, R.J. O'Keefe, and E.M. Schwartz A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-α TGF-β in RANKL-mediated osteoclastogenesis Calcif Tissue Int 73 2003 584 593
21. 1 in osteoclast differentiation and survival J Cell Sci 113 2000 2445 2453
22. 1 (TGF-β) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment Bone 28 2001 577 582
23. R. Battaglino, J. Fu, U. Späte, U. Ersoy, M. Joe, and L. Sedoghat Serotonin regulates osteoclast differentiation through its transporter J Bone Miner Res 19 2004 1420 1431
24. H. Brandstrom, T. Bjorkman, and O. Ljunggren Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells Biochem Biophys Res Commun 280 2001 831 835
25. N. Sasaki, E. Kusano, Y. Ando, K. Yano, E. Tsuda, and Y. Asano Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis Nephrol Dial Transplant 16 2001 479 482
26. N. Sasaki, E. Kusano, Y. Ando, J. Nemoto, O. Iimura, and C. Ito Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis Bone 30 2002 583 858
27. M.N. Weitzmann, C. Roggia, G. Toraldo, L. Weitzmann, and R. Pacifici Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency J Clin Invest 110 2002 1643 1650
28. H. Zhou, V. Kartsogiannis, J.M. Quinn, C. Ly, C. Gange, and J. Elliott Osteoclast inhibitory lectin-a family of new osteoclast inhibitors J Biol Chem 277 2002 48808 48815
29. A. Rogers, G. Saleh, R.A. Hannon, D. Greenfield, and R. Eastell Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women J Clin Endocrinol Metab 87 2002 4470 4475
30. K. Yano, E. Tsuda, N. Washida, F. Kobayashi, M. Goto, and A. Harada Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis J Bone Miner Res 14 1999 518 527
31. W.S. Browner, L.Y. Lui, and S.R. Cummings Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women J Clin Endocrinol Metab 86 2001 631 637
32. S.D. Neale, E. Schulze, R. Smith, and N.A. Athanasou The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease QJM 95 2002 233 240